12:00 AM
 | 
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Bexsero regulatory update

Novartis said Australia's Therapeutic Goods Administration ( TGA) approved Bexsero to vaccinate against meningococcal disease in individuals...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >